Magnus Gustafsson

Chief Business Officer at Biovian

Magnus Gustafsson works as Chief Business Officer at Biovian, a premium Nordic Bio-CDMO providing Manufacturing Happiness for its global clients. In addition to solid business experience, Gustafsson has a scientific background, with more than 20 peer-reviewed articles, and has spent 20 years in various commercial positions executing academic and corporate collaborations, sales management, project management, business development, partnership negotiations and agreements. Magnus holds an MSc in Biochemical Engineering, a PhD in Medical Biochemistry and Biophysics and an MBA.

__________________

Fri. February 24 | 3:00pm – Viral vector development and manufacture.

Different therapeutic gene delivery modalities
Why are viral vectors transformational?
How does modality size increase manufacturing complexity?
Gene therapy products currently in clinical trials or on the market?
How do viral vectors deliver their gene?
What’s the difference between Viral Vectors commonly used in clinical trials?
What is adeno associated virus (AAV)?
Viral vector manufacturing processes used by Biovian